Photobiomodulation (PBM) for Oncology

What is PBM?

Photobiomodulation (PBM) uses monochromatic light in the red and near-infrared spectrum to improve the speed and quality of tissue repair, reduce inflammation, and relieve pain.

What is PBM for?

NICE recommends PBM to prevent and treat oral mucositis, reducing the incidence of Grade 3 and 4 Oral Mucositis by 70%. THOR's equipment can also be used to treat a number of late effects of cancer treatment.

THOR's equipment improves the speed and quality of repair for dermal and subdermal tissue damaged by treatment. It can reduce the swelling and inflammation that can occur as a result of cancer treatment.

Simple. Quick. Effective.

Treating with the THOR equipment takes minutes. It is so simple that patients can treat themselves.

Acquisition and Implementation

We know that institutional purchases can be bureaucratic and slow. THOR can help. We can also assist you in getting the purchase funded.

THOR's products are proven cost-effective, reducing the use of analgesia, feeding tubes, and unplanned hospital admissions.

For late effects, there are down-the-line savings (related to radiation fibrosis, radiation dermatitis, lymphedema, swallowing, dry mouth and speech).

THOR LX2 Dental Package for a range of oral pathologies, orthodontic procedures and orofacial pain syndromes.

CLICK HERE to contact sales

Training course information

Photobiomodulation (PBM) / Low Level Laser Therapy (LLLT) oral mucositis

Annette Quinn - Oral Mucositis Academy of Laser Dentistry 2016 View it on YouTube

Product information and purchase enquiry

Sorry for the long form.

We are a global company and our computer needs to know who to direct your enquiry to.

* Mandatory field - this automatically directs your enquiry to the correct department

First Name*

Last Name*

Profession*

Hospital/Clinic/Team

Region*

Zip or Postal Code*

Country*

Email*

Phone*

Who introduced you to us?*

Comments

THOR Photobiomodulation Newsletter

See previous edition. Please add me to the monthly THOR training, research and conference Newsletter.

First Name *

Last Name *

Email Address *

City

State/Province/Region

Postal / Zip Code

Country *

THOR Photomedicine Ltd is an ISO 13485:2016 certified medical device company.

The THOR LX2.3 Photobiomodulation system has a medical CE mark (EC certificate). It is indicated for oral mucositis, tendinopathies, joint pain, neck pain and back pain for marketing in the UK, EU and Australia.

The THOR LX2.3 Photobiomodulation system is also FDA Cleared for marketing in the United States for: Temporary increase in local blood circulation, temporary relief of minor muscle and joint aches, pains and stiffness and relaxation of muscles; for muscle spasms, and minor pain and stiffness associated with arthritis.

Excluding the THOR LED Helmet, THOR LX2 and NovoTHOR systems are manufactured under conditions fulfilling the quality system requirements of Annex II, excluding (4), of the directive 93/42/EEC as amended and satisfy the applicable international harmonised standards.

Positive systematic reviews published by:

The British Medical Journal (BMJ), The Lancet, the International Association for the Study of Pain (IASP), the World Health Organisation (WHO), the Multinational Association for Supportive Care in Cancer (MASCC), the European Society for Medical Oncology (ESMO)

Appropriate regulatory clearance or approvals include:

Photobiomodulation Equipment and Training - THOR Photomedicine